Yee, L J <br/><br/>
Interleukin 10 polymorphisms as predictors of sustained response in antiviral therapy for chronic hepatitis C infection.  [electronic resource] 

 -  Hepatology (Baltimore, Md.)  Mar 2001 
 - 708-12 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0270-9139 
<br/><br/><label>Standard No.: </label>10.1053/jhep.2001.22347  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alleles<br/>Antiviral Agents--therapeutic use<br/>Drug Therapy, Combination<br/>Gene Frequency<br/>Genetic Variation<br/>Haplotypes<br/>Hepatitis C, Chronic--drug therapy<br/>Heterozygote<br/>Homozygote<br/>Humans<br/>Interferon alpha-2<br/>Interferon-alpha--therapeutic use<br/>Interleukin-10--genetics<br/>Polymorphism, Genetic<br/>Prognosis<br/>Recombinant Proteins<br/>Ribavirin--therapeutic use